Environmental Impact Assessment for landfill expansion
Sans titreManagement Plan for Water Resources in the Baia de Guanabara
Sans titreWebcapture from a recent training course (Nov 2020) held at the EBI (European Institute of Bioinformatics) that includes Phyre – open to academia and industry
Sans titrePress release from Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Sans titrePress release from Neuroprotexeon on the European Distribution Partnership between NeuroproteXeon and Linde
Sans titreResults from the Phase 1 Trials - Feasibility and safety of delivering xenon to patients undergoing coronary artery bypass graft surgery while on cardiopulmonary bypass: phase I study
Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial
Award of EU-FP7 funding to Alkion BioPharma as part of TriForC consortium working on the commercialization of terpenoids
Sans titreStudy which highlighted that Bd had been introduced into Mallorca
Environmental Impact Assessment for housing development
Phyre identified as a resource within ELIXIR UK node servies
Sans titreCompanies House incorporation of Neuroprotexeon Limited
Sans titrePhase 2 trials results
Evonik press release on relocation of EAB to Tours
Sans titre